Combination Immunotherapy and Antifungal Chemotherapy
نویسندگان
چکیده
منابع مشابه
Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges
Candida albicans is the most common cause of invasive candidiasis, but in recent years the incidence of infections caused by other species such as Candida Kruzei, Candida glabrata, Candida tropicalis, Candida parapsilosis and Candida lusitania has increased. In the last decade, the treatment methods for invasive candidiasis have changed completely, and a successful treatment depends on the time...
متن کاملChemotherapy and immunotherapy combination in advanced prostate cancer.
In prostate cancer, there is considerable evidence that tumors promote immune tolerance starting early in the disease. By suppressing tumors and activating immune system homeostatic mechanisms, chemotherapy may help overcome this tumor-induced immune tolerance. As such, chemotherapy may therefore support improved results from novel immune-modulating therapies. Prostate cancer is particularly su...
متن کاملAntibody Peptide Based Antifungal Immunotherapy
Fungal infections still represent relevant human illnesses worldwide and some are accompanied by unacceptably high mortality rates. The limited current availability of effective and safe antifungal agents makes the development of new drugs and approaches of antifungal vaccination/immunotherapy every day more needed. Among them, small antibody(Ab)-derived peptides are arousing great expectations...
متن کاملCombination antifungal therapy.
Combination Antifungal Therapy Melissa D. Johnson,* Conan MacDougall, Luis Ostrosky-Zeichner, John R. Perfect, and John H. Rex Departments of Medicine, and Pharmacy, Duke University Medical Center, Durham, and Campbell University School of Pharmacy, Buies Creek, North Carolina; Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Re-emerging Pat...
متن کاملCandida endocarditis treated with a combination of antifungal chemotherapy and aortic valve replacement.
A case of Candida albicans endocarditis is described in which treatment with 5-fluorocytosine was started after aortic valve replacement, but relapse followed discontinuance of treatment. At a second operation the aortic valve was replaced under 5-fluorocytosine cover and treatment was continued with both 5-fluorocytosine and amphotericin-B. No resistance to 5-fluorocytosine developed, and the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 1998
ISSN: 1058-4838,1537-6591
DOI: 10.1086/516362